Early detection of asthma exacerbations by using action points in self-management plans

European Respiratory Journal

Volumn 41, Issue 1, 2013, Pages 53-59

  Honkoop, Persijn J ^a   Taylor, D Robin ^b   Smith, Andrew D ^b   Snoeck Stroband, Jiska B ^a   Sont, Jacob K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Peak flow; Prediction; Quality control analysis; Symptoms

Indexed keywords

PREDNISONE;

ADULT; AGED; ARTICLE; ASTHMA; CHILD; DIAGNOSTIC ACCURACY; DISEASE EXACERBATION; DRUG EFFECT; DRUG USE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; SELF CARE; SENSITIVITY AND SPECIFICITY; SYMPTOM; TREATMENT DURATION; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; ASTHMA; CHILD; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; SELF CARE; YOUNG ADULT;

EID: 84872181278     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00205911     Document Type: Article

References (23)

1. O'Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet 2006; 368: 794-803.
2. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program (NAEPP) Expert panel report 3. Guidelines for the diagnosis and management of asthma. Bethesda, NHLBI, 2007.
3. Global strategy for asthma management and prevention. Global initiative for asthma. 2006. www.who.int/respiratory/asthma/GINA-WR-2006-copyright%5b1%5d. pdf Date last accessed: October 31, 2012.
4. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations. Am J Respir Crit Care Med 2009; 180: 59-99.
5. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British Guideline on the management of Asthma. A national clinical guideline. London, British Thoracic Society, 2008.
6. The Asthma and Respiratory Foundation of New Zealand. Asthma Self-management Plan 2010. Wellington, The Asthma and Respiratory Foundation of New Zealand.
7. Gibson PG, Wlodarczyk J, Hensley MJ, et al. Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma. Ann Intern Med 1995; 123: 488-492.
8. Gibson PG, Powell H.Written action plans for asthma: an evidence-based review of the key components. Thorax 2004; 59: 94-99.
9. The Dutch General Practice Society (NHG) guideline. Asthma in adults. 2007. http://nhg.artsennet.nl/kenniscentrum/k-richtlijnen/k-nhgstandaarden/ Samenvattingskaartje-NHGStandaard/M27-svk.htm Date last accessed: October 31, 2012.
10. Taylor DR, Town GI, Herbison GP, et al. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 1998; 53: 744-752.
11. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163-2173.
12. Powell H, Gibson PG. Options for self-management education for adults with asthma. Cochrane Database Syst Rev 2003; 1: CD004107.
13. van der Meer V, Bakker MJ, Van Den Hout WB, et al. Internet-based self-management plus education compared with usual care in asthma: a randomized trial. Ann Intern Med 2009; 151: 110-120.
14. Reddel HK. Peak flow monitoring in clinical practice and clinical asthma trials. Curr Opin Pulm Med 2006; 12: 75-81.
15. van der Meer V, Rikkers-Mutsaerts ER, Sterk PJ, et al. Compliance and reliability of electronic PEF monitoring in adolescents with asthma. Thorax 2006; 61: 457-458.
16. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999; 160: 594-599.
17. Thamrin C, Zindel J, Nydegger R, et al. Predicting future risk of asthma exacerbations using individual conditional probabilities. J Allergy Clin Immunol 2011; 127: 1494-1502.
18. Chan-Yeung M, Chang JH, Manfreda J, et al. Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma. Am J Respir Crit Care Med 1996; 154: 889-893.
19. Oborne J, Mortimer K, Hubbard RB, et al. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized double blind, placebo controlled, parallel group, clinical trial. Am J Respir Crit Care Med 2010; 180: 598-602.
20. Juniper EF, Svensson K, Mörk AC, et al. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99: 553-558.
21. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
22. Frey U, Brodbeck T, Majumdar A, et al. Risk of severe asthma episodes predicted from fluctuation analysis of airway function. Nature 2005; 438: 667-670.
23. Taylor DR, Drazen JM, Herbison GP, et al. Asthma exacerbations during long term β-agonist use: influence of β2 adrenoceptor polymorphism. Thorax 2000; 55: 762-767.